NCT01361204

Brief Summary

Long-term practices in a hospital setting and community pharmacy might induce chronic stress in students. Alterations of salivary amylase activity will be measured in students during pharmacy practices as a marker of stress. Theanine is reported to have anti-stress effect on experimental animals under chronic stress and on humans under short-term stress. The purpose of this study is to measure stress symptoms in students during long-term pharmacy practices and to evaluate the efficacy of theanine in suppressing chronic stress, by measuring the salivary amylase activity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2011

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2011

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

May 10, 2011

Completed
16 days until next milestone

First Posted

Study publicly available on registry

May 26, 2011

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2011

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2012

Completed
Last Updated

July 16, 2013

Status Verified

July 1, 2013

Enrollment Period

7 months

First QC Date

May 10, 2011

Last Update Submit

July 14, 2013

Conditions

Keywords

stressstudentspharmacy practicetheaninepharmacy training

Outcome Measures

Primary Outcomes (1)

  • Alterations in salivary amylase activity in students with pharmacy practices

    10 days

Secondary Outcomes (4)

  • Numbers of students deteriorated physical condition

    10 days

  • Incidence of days of coming late or leaving early

    10 days

  • Alterations in sleeping hours from baseline

    10 days

  • Alterations in the response to a stress questionnaire from baseline

    10 days

Study Arms (1)

Theanine

EXPERIMENTAL

Experimental Comparator, theanine Taking 4 tablets of theanine two times daily for 16 days Placebo Comparator, sucrose Taking 4 tablets of sucrose two times daily for 16 days

Dietary Supplement: Theanine

Interventions

TheanineDIETARY_SUPPLEMENT

Taking 4 tablets of theanine two times daily for 16 days

Theanine

Eligibility Criteria

Age22 Months - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Students of pharmaceutical sciences in the fifth grade, nonsmoker
  • Obtained written informed consent from the student before participation
  • Possible to take tablets for 16 days
  • Possible to check salivary amylase activity two times daily for 10 days

You may not qualify if:

  • Taking tranquilizer(s)
  • Smoker
  • Diagnosed as inadequate to participate in the study by a doctor

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Shizuoka

Shizuoka, Shizuoka, 422-8526, Japan

Location

MeSH Terms

Interventions

theanine

Study Officials

  • Unno, Keiko

    University of Shizuoka

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 10, 2011

First Posted

May 26, 2011

Study Start

May 1, 2011

Primary Completion

December 1, 2011

Study Completion

April 1, 2012

Last Updated

July 16, 2013

Record last verified: 2013-07

Locations